PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways

Huang, P., Ran, J., Zhu, W., Dai, W., Tang, Y., Lian, P., Huang, X., & Li, R. (2024). PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways. The FASEB Journal, 38(4). Portico. https://doi.org/10.1096/fj.202301748r
Authors:
Piaopiao Huang
Juanli Ran
Wenqiang Zhu
Wenli Dai
Yaxin Tang
Pingan Lian
Xiansheng Huang
Rong Hui Li
Affiliated Authors:
Wenli Dai
Columbia Affiliation:
Subjects:
Proprotein Convertase 9 (MeSH)
Non-alcoholic Fatty Liver Disease (MeSH)
Epidemiology and Management of NAFLD (OpenAlex Topic)
Cholesterol Metabolism and Atherosclerosis (OpenAlex Topic)
Cholesterol-lowering Treatment (OpenAlex Topic)
Author Keywords:
cholesterol
hepatic steatosis
proprotein convertase subtilisin kexin type 9
receptor
second-generation antipsychotic drugs
triglyceride
elink
Publication Type:
Article
Unique ID:
10.1096/fj.202301748r
PMID:
38358343
DOI:
10.1096/fj.202301748r
Journal:
FASEB Journal
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: